Effects of deferoxamine on ischemia/reperfusion injury after peripheral nerve compression

Annals of Plastic Surgery

Volumn 36, Issue 4, 1996, Pages 365-369

  Li, Yongbo ^a   Bickel, Kyle D ^a   Im, Michael J ^a,b   Hu, Liangbiao ^a   Lee Dellon, A ^a   Vander Kolk, Craig A ^a   Manson, Paul N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; DEFEROXAMINE; MALONALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECOMPRESSION SURGERY; DRUG SCREENING; MALE; NERVE COMPRESSION; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCIATIC NERVE;

EID: 0029919905     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-199604000-00007     Document Type: Article

References (29)

1. Podhajsky RJ, Myers RR. The vascular response to nerve crush: relationship to Wallerian degeneration and regeneration. Brain Res 1993;623:117-123
2. Rydevik B, Nordborg C, Changes in nerve function and nerve fibre structure induced by acute, graded compression. J Neurol Neurosurg Psychiatry 1980;43:1070-1082
3. Fern R, Harrison PJ. The contribution of ischemia and deformation to the conduction block generated by compression of the cat sciatic nerve. Exp Physiol 1994;79:583-592
4. Dahlin LB, Shyu BC, Danielsen N, et al. Effects of nerve compression or ischemia on conduction properties of myelinated and non-myelinated nerve fibres: an experimental study in the rabbit common peroneal nerve. Acta Physiol Scand 1989;136:97-105
5. Gelberman RH, Hergenroeder PT, Hargens AR, et al. The carpal tunnel syndrome. J Bone Joint Surg [Am] 1981;63:380-383
6. Dahlin LB, Thambert C. Acute nerve compression at low pressure has a conditioning lesion effect on rat sciatic nerves. Acta Orthop Scand 1993;64:479-481
7. Fern R, Harrison PJ. The effects of compression upon conduction in myelinated axons of the isolated frog sciatic nerve. J Physiol (Lond) 1991;432:111-122
8. Drossos G, Lazou A, Panagopoulos P, et al. Deferoxamine cardioplegia reduces superoxide radical production in human myocardium. Ann Thorac Surg 1995;59:169-172
9. Schmeling DJ, Caty MG, Oldham KT, et al. Cytoprotection by diclofenac sodium after intestinal ischemia/reperfusion injury. J Pediatr Surg 1994;29:1044-1048
10. Gehlbach P, Purple RL. Enhancement of retinal recovery by conjugated deferoxamine after ischemia-reperfusion. Invest Ophthalmol Vis Sci 1994;35:669-676
11. Dorion D, Zhong A, Chiu G, et al. Role of xanthine oxidase in reperfusion injury of ischemic skeletal muscles in the pig and human. J Appl Physiol 1993;75:246-255
12. Qayumi AK, Janusz MT, Jamieson WR, et al. Pharmacologic interventions for prevention of spinal cord injury caused by aortic crossclamping. J Thorac Cardiovasc Surg 1992;104:256-261
13. Angel MF, Mellow CG, Knight KR, et al. The effect of deferoxamine on tolerance to secondary ischaemia caused by venous obstruction. Br J Plast Surg 1989;42:422-424
14. Ress AM, Babovic S, Angel MF, et al. Free radical damage in acute nerve compression. Ann Plast Surg 1995;34:388-395
15. Del Maestro RF, Thaw HH, Bjork J, et al. Free radicals as mediators of tissue injury. Acta Physiol Scand Suppl 1980;492:43-57
16. Woolf CJ, Reynolds ML, Chong MS, et al. Denervation of the motor endplate results in the rapid expression by terminal Schwann cells of the growth-associated protein GAP-43. J Neurosci 1992;10:3999-4010
17. Wiese UH, Emson PC, Sheppard RC. Production and characterization of an anti-peptide antibody specific for the growth-associated protein, GAP-43. Brain Res 1991;554:145-152
18. Curtis R, Stewart HS, Hall SM, et al. GAP-43 is expressed by nonmyelin-forming Schwann cells of the peripheral nervous system. J Cell Biol 1992;116:1455-1464
19. Wiese UH, Ruth JL, Emson PC. Differential expression of growth-associated protein (GAP-43) mRNA in rat primary sensory neurons after peripheral nerve lesion: a non-radioactive in situ hybridization study. Brain Res 1992;592:141-156
20. Skene JH, Jacobson RD, Snipes GJ, et al. A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes. Science 1986;233:783-786
21. Yagi K. Assay for blood plasma or serum. Methods Enzymol 1984;105:328-331
22. Shin MS, Angel MF, Im MJ, et al. Effects of 21-amínosteroid U74389F on skin flap survival after secondary ischemia. Plast Reconstr Surg 1994;94:661-666
23. Myers RR. Anatomy and microanatomy of peripheral nerve. Neurosurg Clin N Am 1991;2:1-20
24. Muller H, Williams LR, Varon S. Nerve regeneration chamber: evaluation of exogenous agents applied by multiple injections. Brain Res 1987;413:320-326
25. Dellon ES, Dellon AL. Functional assessment of neurologic impairment: track analysis in diabetic and compression neuropathies. Plast Reconstr Surg 1991;88:686-694
26. Keeley R, Atagi T, Sabelman E, et al. Peripheral nerve regeneration across 14-mm gaps: a comparison of autograft and entubulation repair methods in the rat. J Reconstr Microsurg 1993;9:349-358
27. Alderson K, Pestronk A, Yee WC, et al. Silver cholinesterase immunocytochemistry: a new neuromuscular junction stain. Muscle Nerve 1989;12:9-14
28. Wujek JR, Lasek RJ. Correlation of axonal regeneration and slow component B in two branches of a single axon. J Neurosci 1983;3:243-251
29. Basi GS, Jacobson RD, Virag I, et al. Primary structure and transcriptional regulation of GAP-43, a protein associated with nerve growth. Cell 1987;49:785-791